Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 31, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, January 30, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Lim Maintained (ADNT) at Buy with Decreased Target to $75 on, Jan 30th, 2018
David Lim of Wells Fargo, Maintained "Adient plc" (ADNT) at Buy with Decreased Target from $85 to $75 on, Jan 30th, 2018.
David has made no other calls on ADNT in the last 4 months.
There are 3 other peers that have a rating on ADNT. Out of the 3 peers that are also analyzing ADNT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joseph Spak of "RBC Capital" Downgraded from Buy to Hold on, Monday, January 22nd, 2018
These are the ratings of the 2 analyists that currently disagree with David
- Colin Langan of "UBS" Maintained at Strong Buy with Decreased Target to $92 on, Thursday, January 25th, 2018
- Ryan Brinkman of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $74 on, Monday, January 22nd, 2018
